Bio Pharma Dive
SEPTEMBER 22, 2020
Study data show Blueprint's first approved cancer drug, Ayvakit, could also work to treat a rare disease, a result that sent the company's shares higher.
Drug Patent Watch
SEPTEMBER 22, 2020
Don’t wait until the end of the year to start looking for alternatives to your existing business intelligence providers. DrugPatentWatch can help you replace or supplement your current solutions with:…. The post Switching to DrugPatentWatch appeared first on DrugPatentWatch - Make Better Decisions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
SEPTEMBER 22, 2020
The biotech's immunotherapy Libtayo looks headed for approval in lung cancer, but surpassing the bar set by Merck's Keytruda remains a challenge.
BioSpace
SEPTEMBER 22, 2020
Although the updated guidance has largely remained under wraps, sources who spoke to The Washington Post hinted that the new rules would make it more difficult for an EUA to be granted to a vaccine ahead of Nov. 3, the day of the U.S. elections.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
SEPTEMBER 22, 2020
The FDA could decide the fate of Bristol Myers' multiple myeloma treatment ide-cel four days before a key deadline related to the pharma's buyout of Celgene passes.
Scienmag
SEPTEMBER 22, 2020
Credit: Illustration: Denis Baranov, Chalmers University of Technology Physicists at Chalmers University of Technology in Sweden, together with colleagues in Russia and Poland, have managed to achieve ultrastrong coupling between light and matter at room temperature. The discovery is of importance for fundamental research and might pave the way for advances within, for example, light […].
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
SEPTEMBER 22, 2020
The new facility will be 14,000 square feet and is designed from start to finish to meet global current Good Manufacturing Practice (cGMP) standards for radiopharmaceutical manufacturing.
pharmaphorum
SEPTEMBER 22, 2020
A UK university has struck a partnership with medical technology firm Better that aims to give nursing and pharmacy students a better insight into e-prescribing. Liverpool John Moores University is to use Better’s OPENeP electronic prescribing and medicines administration software to teach the students about modern prescribing practices. OPENeP is designed as a stand-alone product that allows electronic patient record systems to be integrated with medication-related decision support systems.
XTalks
SEPTEMBER 22, 2020
The San Francisco-based tech giant, Fitbit, has received clearance from the US Food and Drug Administration (FDA) and the Conformité Européenne (CE) in the European Union for its electrocardiogram (ECG) app. The application is used to assess heart rhythm for atrial fibrillation (AFib). AFib is an irregular heartbeat, known as arrhythmia, that can lead to blood clots, stroke, heart failure and other heart-related complications.
pharmaphorum
SEPTEMBER 22, 2020
New research from The Patients Association, supported through sponsorship provided by Novo Nordisk and ENGINE MHP, looks at how more than 950 patients experienced the COVID-19 pandemic, with an emphasis on managing and accessing care and their experiences of treatment and services more broadly. Here, Patients Association CEO Rachel Power and ENGINE MHP director Jonathon Sheppard explore some of the findings – such as major disruptions to the relationships between patients and the health and care
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioSpace
SEPTEMBER 22, 2020
Often times, you can fall into a trap of seeing a particular title, skimming a listing, and firing off an application.
Forte Research Systems®
SEPTEMBER 22, 2020
Clinical Research Coordinators are tasked with many responsibilities throughout the day. Learn more about how to balance each role and responsibility effectively.
XTalks
SEPTEMBER 22, 2020
MIT engineers have designed a food sensor , made from an array of silk microneedles, that can pierce through the plastic packaging of foods to sample for bacterial contamination and spoilage. The Velco-like device pierces the packaging and the food via silk microneedles that suck in material through capillary action. Once the tiny holes on the needles draw fluid towards the back of the sensor, the analysis occurs.
BioPharma Reporter
SEPTEMBER 22, 2020
AstraZeneca paused its COVID-19 vaccine trial earlier this month for a safety review â generating headlines across mainstream press worldwide. Such pauses are not uncommon in clinical trials â so whatâs the best way to deal with them?
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
BioSpace
SEPTEMBER 22, 2020
A study published today showed that researchers have discovered an active role for glycans, the sugar molecules that decorate proteins. In turn, there may be new targets for certain therapies, and this could help experts looking to develop a vaccine for COVID-19.
BioPharma Reporter
SEPTEMBER 22, 2020
A project run by Gavi, the vaccine alliance, and the World Health Organization (WHO) to guarantee fair access to COVID-19 vaccines worldwide has secured the backing of 64 higher income economies, with a further 38 economies expected to sign in the coming days.
Pharma in Brief
SEPTEMBER 22, 2020
On September 16, 2020, the Minister of Health signed an Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 (the Interim Order ) which provides new regulatory pathways to expedite the approval of COVID-19 drugs and vaccines that have not yet been approved for sale in Canada. It also allows for addition of new indications related to COVID-19 that are not included in a currently-marketed product’s authorization.
BioSpace
SEPTEMBER 22, 2020
In a brief statement, Genmab said it initiated binding arbitration related to two matters under its Darzalex (daratumumab) license agreement with Janssen Biotech.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
SEPTEMBER 22, 2020
Credit: Karyosoft/Rajesh Perianayagam WEST LAFAYETTE, Ind. – A Purdue Foundry-affiliated company with a growing reputation as a search engine for genome sequence data in life sciences has joined a nationally ranked health care startup accelerator. Karyosoft is among nine startups from across the globe selected for the Dallas-based seed accelerator Health Wildcatters.
XTalks
SEPTEMBER 22, 2020
A new study shows that the diabetic drug canagliflozin reduces the risk of adverse cardiovascular and kidney outcomes in individuals with type 2 diabetes, particularly for those at higher risk of kidney failure. The Canagliflozin Cardiovascular Assessment Study (CANVAS) Program evaluated patients with type 2 diabetes who are at high cardiovascular risk.
Scienmag
SEPTEMBER 22, 2020
Brazilian researchers observed that in uninfected adipocytes, the hormone irisin altered the expression of genes that regulate ACE-2, which encodes a protein to which the virus binds in order to invade human cells. Credit: Miriane de Oliveira A study conducted by researchers at São Paulo State University (UNESP) suggests that irisin, a hormone secreted from […].
Intouch Solutions
SEPTEMBER 22, 2020
Today, the voices of influencers are vital. They can be gatekeepers to their audiences and authenticators of brand messaging, serving as extended voices of a brand. So how can pharma work well with health influencers, and to do so with expert precision? Find out here! The post Bringing Health Influencers Into Your Brand appeared first on Intouch Solutions.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
SEPTEMBER 22, 2020
Carnegie Mellon’s Maysam Chamanzar has developed a new class of materials for optical biointerfaces Credit: Carnegie Mellon University College of Engineering Carnegie Mellon University’s Maysam Chamanzar and his team have invented an optical platform that will likely become the new standard in optical biointerfaces. He’s labeled this new field of optical technology “Parylene photonics,” demonstrated […].
BioSpace
SEPTEMBER 22, 2020
RNA-binding proteins are emerging as the next generation of molecular medicine.
Scienmag
SEPTEMBER 22, 2020
International team of researchers finds the region has become greener as warmer air and soil temperatures lead to increased plant growth Credit: Logan Berner, Northern Arizona University As Arctic summers warm, Earth’s northern landscapes are changing. Using satellite images to track global tundra ecosystems over decades, a team of researchers finds the region has become […].
Pharma Times
SEPTEMBER 22, 2020
Data presented at 2020 ESMO virtual congress
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
SEPTEMBER 22, 2020
Credit: Credit: NASA/NOAA/NRL Tropical Storm Paulette just reformed in the central North Atlantic Ocean today, Sept. 22. Using a NASA satellite rainfall product that incorporates data from satellites and observations, NASA estimated Paulette’s rainfall rates. Paulette was a hurricane whose eye passed directly over Bermuda, then weakened and became a post-tropical cyclone on Sept. 16 […].
BioSpace
SEPTEMBER 22, 2020
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 23, 2020.
Scienmag
SEPTEMBER 22, 2020
Pre-clinical study suggests virus does not stay in the lungs but spreads throughout the mother’s body Credit: RMIT University New research helps explain why flu can lead to life-threatening complications during pregnancy, suggesting the virus does not stay in the lungs but spreads throughout the mother’s body. The pre-clinical study has overturned current scientific thinking […].
pharmaphorum
SEPTEMBER 22, 2020
Online Pharma Forecasting Training for Individuals or Groups is Now Available. Pharmaceutical forecasting can be challenging particularly during this time. Recognised as the pharmaceutical forecasting experts, J+D Forecasting has created several online pharma forecasting courses. Following the success of J+D Forecasting’s face to face training , the content has been redesigned to make it suitable for an online audience.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
286 
Let's personalize your content